Incannex Healthcare Inc stock is traded at $2.27, with a volume of 119,613. It is down -8.84% in the last 24 hours and down -29.28% over the past month. Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Previous Close:
$2.49
Open:
$2.48
24h Volume:
119,613
Relative Volume:
1.61
Market Cap:
$28.48M
Revenue:
$12,000
Net Income/Loss:
-$48.41M
P/E Ratio:
-
EPS:
-$17.18
Net Cash Flow:
-$19.99M
1W Performance:
-12.02%
1M Performance:
-29.28%
6M Performance:
-52.21%
1Y Performance:
-79.92%
1-Day Range:
$2.24$2.64
1-Week Range:
$2.17$2.66
52-Week Range:
$2.17$14.91
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare IncSector
HealthcarePhone
61 409 840 786Address
8 CENTURY CIRCUIT, NORWEST NSW, AustraliaMarket Cap
Revenue
Net Income
Cash Flow
EPS